Fenebrutinib wk12 results for both cohorts. Does not look better than ADA (secondary endpoint)
#ACR19 @rheumnow Abst0929 https://t.co/vIygXGn4vT
Links:
Nov-11-2019
Search for Terms or Answers
Search for Terms or Answers
Links:
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
